Target intelligence / Profile preview

STAG3L5P-PVRIG2P-PILRB readthrough

Molecular classification
Other
01

Overview

The entry "STAG3L5P-PVRIG2P-PILRB readthrough" refers to a complex locus or readthrough transcript annotation involving multiple gene symbols and pseudogenes, including PILRB (Paired immunoglobulin-like type 2 receptor beta), as well as two predicted or pseudogene elements: STAG3L5P and PVRIG2P. PILRB is a recognized immunoregulatory receptor involved in activating immune cell signaling, but the combined term is not a standard or canonical protein/gene/receptor recognized in scientific databases. This suggests confusion of gene annotations, likely referencing a *readthrough transcription event* or a *chimeric/artefactual* annotation common in large-scale genomics projects. As such, it is **not a validated or actionable therapeutic target** and should not be considered an individual protein, receptor, or drug target. **Note:** PILRB alone (Paired immunoglobulin-like type 2 receptor beta) is a biologically characterized immune cell receptor, but "STAG3L5P-PVRIG2P-PILRB readthrough" is a non-canonical, likely artefactual, multi-locus transcript and not a proper molecular target. The inclusion of pseudogenes and "readthrough" terminology indicates a likely misannotation or computational artifact rather than a distinct entity with known structure/function or therapeutic relevance.

Other names
STAG3L5P-PVRIG2P-PILRBFDFACTLOC101735302-LOC101752334-PILRBPILRBActivating receptor PILR-betaCell surface receptor FDFACTLOC101735302-LOC101752334-PILRB readthroughPaired immunoglobulin-like type 2 receptor betastromal antigen 3 pseudogenestromal antigen 3-like 5 pseudogeneSTAG3L5P
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on STAG3L5P-PVRIG2P-PILRB readthrough.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STAG3L5P-PVRIG2P-PILRB readthrough.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call